These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18602190)

  • 1. Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?
    Cunningham R; Dial S
    J Hosp Infect; 2008 Sep; 70(1):1-6. PubMed ID: 18602190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?
    Jump RL; Pultz MJ; Donskey CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2883-7. PubMed ID: 17562803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
    Hong SH; Lee EK; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.
    Biswal S
    Biomed J; 2014; 37(4):178-83. PubMed ID: 25116712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
    Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
    Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
    Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
    Kaneria MV; Paul S
    J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
    Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
    J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.
    Bauer MP; Goorhuis A; Koster T; Numan-Ruberg SC; Hagen EC; Debast SB; Kuijper EJ; van Dissel JT
    Neth J Med; 2008 May; 66(5):207-11. PubMed ID: 18490799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
    Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L
    Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
    Choudhry MN; Soran H; Ziglam HM
    QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.
    Al-Tureihi FI; Hassoun A; Wolf-Klein G; Isenberg H
    J Am Med Dir Assoc; 2005; 6(2):105-8. PubMed ID: 15871884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established and potential risk factors for Clostridum difficile infection.
    Vaishnavi C
    Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
    Kim JW; Lee KL; Jeong JB; Kim BG; Shin S; Kim JS; Jung HC; Song IS
    World J Gastroenterol; 2010 Jul; 16(28):3573-7. PubMed ID: 20653067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of Clostridium difficile-associated diarrhoea in a community hospital.
    Tomkins K; Raynor J; Rothwell L; DeSilva J; Wilson C
    West Indian Med J; 2011 Jan; 60(1):57-60. PubMed ID: 21809713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series.
    MacConnachie AA; Fox R; Kennedy DR; Seaton RA
    QJM; 2009 Nov; 102(11):781-4. PubMed ID: 19726581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.
    Baxter R; Ray GT; Fireman BH
    Infect Control Hosp Epidemiol; 2008 Jan; 29(1):44-50. PubMed ID: 18171186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.